Teva Pharmaceutical Industries Limited

TEVJF | PNK | 0 Sledující

$17.80

10.49%

$1.69

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	16,544,000 +4.40%	15,846,000 +6.17%	14,925,000 -6.00%	15,878,000 -
Cost of revenue	8,481,000 +3.43%	8,200,000 +3.12%	7,952,000 -4.01%	8,284,000 -
Gross profit	8,063,000 +5.45%	7,646,000 +9.65%	6,973,000 -8.18%	7,594,000 -
Operating expense	8,366,000 +15.99%	7,213,000 +68.41%	4,283,000 -4.72%	4,495,000 -
Operating income	-303,000 -169.98%	433,000 +120.63%	-2,099,000 -222.32%	1,716,000 -
Pretax Income	-1,284,000 -106.43%	-622,000 +79.71%	-3,065,000 -565.81%	658,000 -
Tax Provision	676,000 +9,757.14%	-7,000 +98.90%	-638,000 -402.37%	211,000 -
Net income	-1,639,000 -193.20%	-559,000 +76.24%	-2,353,000 -664.27%	417,000 -
EPS	-1.45 -190.00%	-0.5 +76.42%	-2.12 -657.89%	0.38 -
Diluted EPS	-1.45 -190.00%	-0.5 +76.42%	-2.12 -657.89%	0.38 -
Average Shares	1,133,000 +1.34%	1,118,000 +0.72%	1,110,000 +0.73%	1,102,000 -
Diluted Average Shares	1,133,000 +1.25%	1,119,000 +0.81%	1,110,000 +0.27%	1,107,000 -
EBIT	-282,000 -169.63%	405,000 +118.14%	-2,233,000 -244.16%	1,549,000 -
EBITDA	777,000 -50.13%	1,558,000 +268.43%	-925,000 -120.98%	4,409,000 -

Soubory cookie používáme ke zlepšení prohlížení na webu.